Loss of Smell and Taste Can Accurately Predict COVID-19 Infection: A Machine-Learning Approach.
María Amparo Callejon-LeblicRamon Moreno-LunaAlfonso Del Cuvillo BernalIsabel M Reyes-TejeroMiguel A Garcia-VillaranMarta Santos-PeñaJuan M Maza-SolanoDaniel Iván Martín-JiménezJose M Palacios-GarciaCarlos Fernandez-VelezJaime González-GarcíaJuan M Sanchez-CalvoJuan Solanellas-SolerSerafin Sanchez-GomezPublished in: Journal of clinical medicine (2021)
The COVID-19 outbreak has spread extensively around the world. Loss of smell and taste have emerged as main predictors for COVID-19. The objective of our study is to develop a comprehensive machine learning (ML) modelling framework to assess the predictive value of smell and taste disorders, along with other symptoms, in COVID-19 infection. A multicenter case-control study was performed, in which suspected cases for COVID-19, who were tested by real-time reverse-transcription polymerase chain reaction (RT-PCR), informed about the presence and severity of their symptoms using visual analog scales (VAS). ML algorithms were applied to the collected data to predict a COVID-19 diagnosis using a 50-fold cross-validation scheme by randomly splitting the patients in training (75%) and testing datasets (25%). A total of 777 patients were included. Loss of smell and taste were found to be the symptoms with higher odds ratios of 6.21 and 2.42 for COVID-19 positivity. The ML algorithms applied reached an average accuracy of 80%, a sensitivity of 82%, and a specificity of 78% when using VAS to predict a COVID-19 diagnosis. This study concludes that smell and taste disorders are accurate predictors, with ML algorithms constituting helpful tools for COVID-19 diagnostic prediction.
Keyphrases
- coronavirus disease
- machine learning
- sars cov
- end stage renal disease
- big data
- newly diagnosed
- ejection fraction
- artificial intelligence
- chronic kidney disease
- prognostic factors
- respiratory syndrome coronavirus
- peritoneal dialysis
- mass spectrometry
- high resolution
- transcription factor
- physical activity
- multidrug resistant
- clinical trial
- data analysis
- patient reported outcomes
- double blind